Calendar · pharmadog

Sign In Subscribe

Date TBD

50

RECRUITINGphase readoutNCT06827236: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerBioNTech SE

Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT04239144: Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas DiseaseUniversity of Sao Paulo General Hospital

Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Chagas Cardiomyopathy, Ventricular Arrythmia

full page →ctgov ↗

RECRUITINGphase readoutNCT06627764: SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant FamiliesDuke University

Sponsor: Duke University. Phase: NA. Conditions: Substance Abuse, Intimate Partner Violence (IPV), HIV Infections, Depression, Anxiety

full page →ctgov ↗

RECRUITINGphase readoutNCT06903364: Association of Lifestyle With Complications in the Diabetic Population

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07534709: Suzetrigine for Opioid-Free Recovery After Cesarean DeliveryVertex, Inc.

Sponsor: University of Texas at Austin. Phase: PHASE4. Conditions: Cesarean Delivery, Cesarean Section, Pain, Postoperative, Opioid Consumption, Postoperative

full page →ctgov ↗

SUSPENDEDphase readoutNCT03604991: Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07528274: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)

full page →ctgov ↗

RECRUITINGphase readoutNCT06865482: Clinical Course Of Disease In Participants With FA-CM

Sponsor: Lexeo Therapeutics. Phase: . Conditions: Friedreich Ataxia, Cardiomyopathy

full page →ctgov ↗

COMPLETEDphase readoutNCT07504224: ASD Wearables Feasibility Study

Sponsor: Rady Pediatric Genomics & Systems Medicine Institute. Phase: NA. Conditions: Autism Spectrum Disorder, Wearable Devices

full page →ctgov ↗

RECRUITINGphase readoutNCT05597124: Exercise to Improve Brain Health in Older African Americans

Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: Aging, Alzheimer Disease, Healthy Aging, Cognitive Change

full page →ctgov ↗

RECRUITINGphase readoutNCT07353723: Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Sponsor: Tang-Du Hospital. Phase: PHASE2. Conditions: Head & Neck Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07118124: Pediatric Adhesion and New Dermal Approach Study

Sponsor: iRhythm Technologies, Inc.. Phase: NA. Conditions: Syncope, Pediatric, Congenital Athymia, Congenital Heart Disease, Arrhythmia, Arrhythmia in Children

full page →ctgov ↗

RECRUITINGphase readoutNCT00250159: Natural History Study of Patients With Excess Androgen

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)

full page →ctgov ↗

RECRUITINGphase readoutNCT04661280: Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Alzheimer Disease, Early Onset

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06972979: Investigation of a Patient Support Intervention for Statin Medication Adherence

Sponsor: Ascension Health. Phase: NA. Conditions: Medication Adherence

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07512596: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

full page →ctgov ↗

RECRUITINGphase readoutNCT07232862: Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Healthy Young Adults

Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05396846: My Best GI Eating Study

Sponsor: University of Michigan. Phase: NA. Conditions: Colorectal Neoplasms

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07418827: Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

Sponsor: Assistance Publique Hopitaux De Marseille. Phase: . Conditions: Haemophilia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05703269: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: NSCLC, Renal Cell Carcinoma, Breast Carcinoma, Melanoma, Brain Metastases, Adult, Non-small Cell Lung Cancer, SCLC, Small-cell Lung Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT03218969: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist

Sponsor: William Ondo, MD. Phase: PHASE1. Conditions: Restless Legs Syndrome, Augmentation

full page →ctgov ↗

RECRUITINGphase readoutNCT05226169: Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Sponsor: Asan Medical Center. Phase: PHASE3. Conditions: Advanced Gastric Carcinoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04762069: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Sponsor: CNS Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Glioblastoma Multiforme, Adult

full page →ctgov ↗

COMPLETEDphase readoutNCT02064569: Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

Sponsor: GenSight Biologics. Phase: PHASE1. Conditions: Leber Hereditary Optic Neuropathy

full page →ctgov ↗

COMPLETEDphase readoutNCT01413269: Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT02784769: Matrix Aging and Aneurysm

Sponsor: CHU de Reims. Phase: NA. Conditions: Aortic Aneurysm

full page →ctgov ↗

RECRUITINGphase readoutNCT06994169: Glofitamab in Real Life

Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Large B-cell Lymphoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07516041: Metaverse- and VR-Supported Education in a Digital Breastfeeding Museum: Long-Term Effects on Breastfeeding Process, Self-Efficacy, and Motivation

Sponsor: Uludag University. Phase: NA. Conditions: Metaverse, Virtual Reality, Digital Museum, Breastfeeding Education, Breastfeeding Self-Efficacy, Breastfeeding Duration, Breastfeeding Motivation, Breastfeeding Problems Assessment

full page →ctgov ↗

COMPLETEDphase readoutNCT03507205: Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

Sponsor: Seoul National University Hospital. Phase: . Conditions: Coronary Artery Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT07470905: Development and Preclinical Validation of DiaBuddy, a Point-of-Care Decision Support Tool for Children With Type 1 Diabetes: A Pilot Clinical Study

Sponsor: Regency Hospital Kanpur. Phase: NA. Conditions: Type 1 Diabetes (T1D)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Sponsor: Target PharmaSolutions, Inc.. Phase: . Conditions: Hepatocellular Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT06189066: Long COVID Ultrasound Trial

Sponsor: SecondWave Systems Inc.. Phase: NA. Conditions: Long Covid

full page →ctgov ↗

RECRUITINGphase readoutNCT07137429: Platelet Volunteers, Longitudinal and Multi-omic Study

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Thrombosis

full page →ctgov ↗

COMPLETEDphase readoutNCT07091929: A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

Sponsor: Beijing Sungen Biomedical Technology Co., Ltd. Phase: PHASE1. Conditions: Anterior Myocardial Infarction

full page →ctgov ↗

COMPLETEDphase readoutNCT06850831: Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Sponsor: dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA. Phase: PHASE2. Conditions: STEMI - ST Elevation Myocardial Infarction (MI), Primary PCI - STEMI

full page →ctgov ↗

COMPLETEDphase readoutNCT07548931: Cold Plasma and Early Microbial Colonization of Healing Abutments

Sponsor: Kahramanmaras Sutcu Imam University. Phase: NA. Conditions: Tooth Loss

full page →ctgov ↗

RECRUITINGphase readoutNCT07370402: The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

full page →ctgov ↗

COMPLETEDphase readoutNCT07456553: Impacted Tooth With Immediate Implant Placement

Sponsor: University of Bari Aldo Moro. Phase: NA. Conditions: Impacted Tooth

full page →ctgov ↗

RECRUITINGphase readoutNCT07400653: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

Sponsor: Pfizer. Phase: PHASE3. Conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07057037: Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

Sponsor: Inventera Inc.. Phase: PHASE3. Conditions: Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis, Rotator Cuff Tendonitis, Articular Cartilage Injury, Glenohumeral Ligament, Long Head Biceps Tendon Tear, Adhesive Capsulitis

full page →ctgov ↗

RECRUITINGphase readoutNCT06166537: GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

Sponsor: Imperial College London. Phase: NA. Conditions: Venous Thromboembolism, Surgery

full page →ctgov ↗

RECRUITINGphase readoutNCT03816345: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel Disease, Malignant Solid Neoplasm, Multiple Sclerosis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Systemic Scleroderma, Ulcerative Colitis

full page →ctgov ↗

RECRUITINGphase readoutNCT06563895: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Sponsor: Eidos Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07320677: Finding Heart Failure in Those Prescribed Loop Diuretics in Primary Care in Jersey

Sponsor: Government of Jersey. Phase: NA. Conditions: Heart Failure, Diuretics

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07523412: Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

Sponsor: Ain Shams University. Phase: PHASE4. Conditions: Peri-implant Bone and Soft Tissues

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07323381: Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM

Sponsor: Bin Lu. Phase: PHASE4. Conditions: Diabetes Type 2

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07533981: ¹²⁹Xe(XENON) MRI Program

Sponsor: Alexei Ouriadov. Phase: NA. Conditions: Healthy Volunteers - Male and Female

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02598219: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Sponsor: Centre Oscar Lambret. Phase: PHASE3. Conditions: Non Endometrioid Carcinoma, Endometrioid Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion

full page →ctgov ↗

TERMINATEDphase readoutNCT05036681: A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma

full page →ctgov ↗

page 3 of 94